DuPont is investing in capabilities and manufacturing capacity for its DuPont Liveo Healthcare Solutions for medical devices, biopharmaceutical processing, and pharmaceutical solutions. The investments include:
- *New elastomer mixers at the company’s dedicated Healthcare Industries Materials Site (HIMS) in Hemlock, MI, USA (pictured above)
- *A new over-molded assembly (OMA) press at HIMS
- *Opening of a new healthcare site for biopharmaceutical processing tubing in Cooper River, SC, USA
- *Added local manufacturing capabilities in China for biopharmaceutical processing tubing designated for regional sales.
“DuPont is committed to pursuing investments in healthcare capabilities to better serve customers around the world and enable them to grow, innovate and save lives,” stated Eugenio Toccalino, global business director, DuPont Healthcare and Specialty Lubricants, in a news release. “As a result of the global biologic production trend –– the reliability and adaptability of single-use components suppliers is more critical than ever. These continued investments are a testament to our long-term commitment to the healthcare industry.”
DuPont had announced the new medical-grade elastomer mixers at HIMS in 2019, and they will be inaugurated on September 29, 2021. They will enable the sustainable growth of the Liveo medical silicone elastomer product lines serving specialty medical device applications, the production expansion of topical formulated excipients, and the expansion of in-house production of Liveo pharmaceutical silicone tubing for biopharmaceutical processing, the company reported. Also, new over-molding press capabilities are scheduled to go online at HIMS in November 2021.
In the second quarter of 2022, DuPont expects to begin operating a second healthcare site in Cooper River, SC. It will initially be used to expand production of silicone pharmaceutical tubing intended for biopharmaceutical processing, and the tubing made in Cooper River will meet the same level of quality management and healthcare regulatory compliance as Liveo pharma tubing products manufactured at HIMS, DuPont reported.
Also in the second half of 2022, DuPont will add silicone pharmaceutical tubing production capacity in China for the region’s fast-growing customers.